Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lansoprazole sodium (Lansoprazole (sodium)) is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease.
説明 | Lansoprazole sodium (Lansoprazole (sodium)) is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease. |
In vivo | Repeated administration of lansoprazole to humans induces the hepatic microsomal P-450-dependent drug oxidation system that mediates N-1-demethylation of theophylline, consequently increasing its metabolism[1]. |
別名 | Lansoprazole (sodium), AG-1749 sodium |
分子量 | 391.34 |
分子式 | C16H13F3N3NaO2S |
CAS No. | 226904-00-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (153.32 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lansoprazole sodium 226904-00-3 Membrane transporter/Ion channel Metabolism Microbiology/Virology Proton pump Phospholipase Antibacterial Lansoprazole AG-1749 sodium Lansoprazole (sodium) AG-1749 sodium Inhibitor inhibitor inhibit